Studies have shown that patients using GLP-1 receptor agonists, alongside lifestyle modifications, can achieve an average weight reduction of 1015% of their body weight over time with improvements in blood sugar control, blood pressure, and cholesterol levels
Published in the New England Journal of Medicine in June 2023, the 48-week phase 2 trial by Jastreboff et al
1 Patients on concomitant insulin therapies or insulin secretagogues are at a higher risk for this adverse event
Sattar N, Lee MMY, Kristensen SL, et al
So, you can toss away your other serum and moisturizer for the time being, as this restorative treatment, designed with a deep understanding of the unique biological changes occurring beneath the surface of the skin, is one to impress
Its quickly becoming an essential component in the mix, similar to the way some require drugs to control hypertension or cholesterol